Press Releases

26/03/2021

MEMSCAP CONFIRMS ITS ELIGIBILITY FOR FRENCH PEA-PME SAVINGS PLANS

... more

24/03/2021

MEMSCAP EARNINGS FOR THE 2020 FISCAL YEAR: POSITIVE OPERATING CASH FLOW AT +EUR 1.5 MILLION

Strong growth of the medical business. Resilience of the Group in the context of global pandemic.... more

28/01/2021

MEMSCAP ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021

... more

27/01/2021

MEMSCAP Q4 2020: STRONG GROWTH OF THE MEDICAL BUSINESS / OPERATING PROFITABILITY OF THE GROUP

Operating profit at +0.1 million euros in Q4 20. Quarterly sales of the medical business multiplied by 2.9 compared to Q4 2019. . Positive quarterly EBITDA at +0.3 million euros / Positive cumulative 12-month EBITDA at +0.8 million euros. Available liquidities at 4.2 million euros on 31 December 2020.... more

08/01/2021

MEMSCAP BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITé S2 2020

... more

26/10/2020

MEMSCAP Q3 2020: QUARTERLY SALES AT 2.4 MILLION EUROS

Significant growth in the medical business partially offsetting the impact of the Covid-19 pandemic on the Group's avionics business. Favourable evolution of the optical communications business over the quarter. Positive quarterly EBITDA / Cumulative 9-month EBITDA exceeding 0.5 million euros. Increase in net cash of +0.1 million euros over Q3 2020 and +1.0 million euros over the first 9 months of the year. Available liquidities at 4.2 million euros at 30 September 2020.... more

31/08/2020

MEMSCAP FIRST HALF 2020 EARNINGS: HALF-YEAR REVENUE OF 6.1 MILLION EUROS

Impact of the Covid-19 pandemic on the Group's avionics business fully offset by the significant growth of the medical business. Optical communications business impacted by the Covid-19 pandemic and the related closure of the US production site for more than two weeks. Half-year operating loss limited to 0.1 million euros.... more

28/07/2020

MEMSCAP Q2 2020: HALF-YEAR REVENUE OF 6.1 MILLION EUROS / Q2 2020 SALES OF 2.7 MILLION EUROS

Impact of the Covid-19 pandemic on the Group's avionics business fully offset by the significant growth of the medical business. Optical communications business impacted by the Covid-19 pandemic and the related closure of the US production site for more than two weeks. Half-year operating loss and Q2 operating loss limited to 0.1 million euros. Half-year EBITDA at 0.5 million euros and Q2 EBITDA at 0.2 million euros despite an unprecedented macroeconomic environment. Increase of available liquidities up to EUR 4.2 million at 30 June 2020.... more

07/07/2020

MEMSCAP BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITé S1 2020

... more

28/05/2020

MINUTES OF THE ANNUAL ORDINARY SHAREHOLDERS’ MEETING OF MAY 28, 2020

... more

Previous   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29   Next

Office to Contact

European Headquarters:

MEMSCAP S.A.

Parc Activillage des Fontaines

ZI Bernin

38 926 Crolles Cedex

France

Phone : +33 (0)4 76 92 85 00

Fax : +33 (0)4 76 92 85 01


Access map: click here 

Financial Reports Calendar

upcoming events:

2021: 1st Quarter revenue and results

read more

Annual Shareholders Meeting

read more
Events & Announcements Calendar